• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性中枢神经系统淋巴瘤的发病率变化主要由中青年男性发病率的变化驱动,与系统性弥漫性大 B 细胞非霍奇金淋巴瘤的时间趋势不同。

The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.

机构信息

Department of Neurology, Mayo Clinic, Rochester, Minnesota; Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota.

出版信息

Am J Hematol. 2013 Dec;88(12):997-1000. doi: 10.1002/ajh.23551. Epub 2013 Sep 12.

DOI:10.1002/ajh.23551
PMID:23873804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4020348/
Abstract

There has been an overall decline in the United States incidence of Primary CNS Lymphoma (PCNSL) from 1998 to 2008. This study's intent was to characterize the cohorts contributing to it. First, calculated the PCNSL incidence rates from nine Surveillance, Epidemiology, and End Results (SEER) registries for time period 1973 to 2008. Second, examined the time trends overall and by age and gender. Third, used 1992-2008 SEER data from the same registries to obtain overall trends for diffuse large B-cell lymphoma (DLBCL). Last, rates were age-adjusted to the 2000 US standard population and reported per 100,000 person-years. Rates continued to increase in women at all ages and men aged 65 and older. In men aged 20-39 and 40-64 years incidence rates peaked in 1995 and then declined dramatically, stabilizing after 1998. The trends in the incidence of PCNSL over this time frame were significantly different from DLBCL for ages 20-39 (P < 0.001) and 40-64 (P < 0.001) years but were not different for the 65 years and older age group (P = 0.99). The overall PCNSL incidence rate declined since 1995 and was driven primarily by the changing incidence in young and middle-aged men. The rate has continued to increase in men aged 65 years and older and in women. The trends in incidence in the younger age groups over this time period did not parallel those observed for DLBCL.

摘要

从 1998 年到 2008 年,美国原发性中枢神经系统淋巴瘤(PCNSL)的发病率总体呈下降趋势。本研究旨在分析导致这一趋势的人群特征。首先,计算了 1973 年至 2008 年期间来自 9 个监测、流行病学和最终结果(SEER)登记处的 PCNSL 发病率。其次,总体和按年龄及性别分析时间趋势。再次,利用来自相同登记处的 1992-2008 年 SEER 数据,获得弥漫性大 B 细胞淋巴瘤(DLBCL)的总体趋势。最后,将发病率按年龄调整为 2000 年美国标准人口,并以每 10 万人年为单位进行报告。所有年龄段的女性和 65 岁及以上的男性发病率仍在持续上升。在 20-39 岁和 40-64 岁的男性中,发病率在 1995 年达到峰值,随后急剧下降,1998 年后趋于稳定。在这段时间内,PCNSL 的发病率趋势与 20-39 岁(P < 0.001)和 40-64 岁(P < 0.001)年龄组的 DLBCL 明显不同,但与 65 岁及以上年龄组(P = 0.99)无差异。自 1995 年以来,PCNSL 的总体发病率呈下降趋势,主要原因是年轻和中年男性的发病率发生变化。65 岁及以上男性和女性的发病率仍在持续上升。在此期间,年轻人群发病率的变化趋势与 DLBCL 观察到的变化趋势并不一致。

相似文献

1
The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma.原发性中枢神经系统淋巴瘤的发病率变化主要由中青年男性发病率的变化驱动,与系统性弥漫性大 B 细胞非霍奇金淋巴瘤的时间趋势不同。
Am J Hematol. 2013 Dec;88(12):997-1000. doi: 10.1002/ajh.23551. Epub 2013 Sep 12.
2
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.1973年至1998年美国卡波西肉瘤和非霍奇金淋巴瘤发病率的趋势。
J Natl Cancer Inst. 2002 Aug 21;94(16):1204-10. doi: 10.1093/jnci/94.16.1204.
3
The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.原发性中枢神经系统非霍奇金淋巴瘤发病率持续上升:一项监测、流行病学及最终结果分析
Cancer. 2002 Oct 1;95(7):1504-10. doi: 10.1002/cncr.10851.
4
Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.加拿大安大略省艾滋病相关卡波西肉瘤和非霍奇金淋巴瘤发病率的变化情况。
Cancer Causes Control. 2008 Dec;19(10):1251-8. doi: 10.1007/s10552-008-9196-8. Epub 2008 Jul 10.
5
Epidemiology of primary CNS lymphoma.原发性中枢神经系统淋巴瘤的流行病学
J Neurooncol. 1999 Jul;43(3):199-201. doi: 10.1023/a:1006290032052.
6
Trends in primary central nervous system lymphoma incidence and survival in the U.S.美国原发性中枢神经系统淋巴瘤的发病率及生存率趋势
Br J Haematol. 2016 Aug;174(3):417-24. doi: 10.1111/bjh.14073. Epub 2016 Mar 28.
7
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.高效抗逆转录病毒疗法与人类免疫缺陷病毒感染成人的癌症发病率
J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30. doi: 10.1093/jnci/92.22.1823.
8
AIDS-related cancer and severity of immunosuppression in persons with AIDS.艾滋病相关癌症与艾滋病患者免疫抑制的严重程度
J Natl Cancer Inst. 2007 Jun 20;99(12):962-72. doi: 10.1093/jnci/djm010. Epub 2007 Jun 12.
9
Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.原发性中枢神经系统非霍奇金淋巴瘤的病理学与临床相关性。麻省总医院1958 - 1989年的经验
Cancer. 1994 Aug 15;74(4):1383-97. doi: 10.1002/1097-0142(19940815)74:4<1383::aid-cncr2820740432>3.0.co;2-1.
10
Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.艾滋病相关癌症标准化发病比导致相对风险被低估。
Ann Epidemiol. 2008 Mar;18(3):230-4. doi: 10.1016/j.annepidem.2007.10.005.

引用本文的文献

1
The Landscape of Primary Central Nervous System Lymphoma (PCNSL): Clinicopathologic and Genomic Characteristics and Therapeutic Perspectives.原发性中枢神经系统淋巴瘤(PCNSL)概述:临床病理及基因组特征与治疗前景
Cancers (Basel). 2025 Sep 4;17(17):2909. doi: 10.3390/cancers17172909.
2
Secondary Versus Recurrent Central Nervous System Lymphoma: Evaluating the Similarities and Differences in a Single-Institution Cohort.继发性与复发性中枢神经系统淋巴瘤:在单机构队列中评估其异同
Cureus. 2025 Jul 9;17(7):e87626. doi: 10.7759/cureus.87626. eCollection 2025 Jul.
3
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.利用三维磁共振成像对原发性中枢神经系统淋巴瘤进行预后评估及反应评估的优化
Neurooncol Adv. 2025 May 5;7(1):vdaf090. doi: 10.1093/noajnl/vdaf090. eCollection 2025 Jan-Dec.
4
Primary Leptomeningeal Lymphoma Presenting As Rapidly Progressive Hydrocephalus: Diagnosis and Symptom Relief Through Endoscopic Ependymal Biopsy and Third Ventriculostomy.以快速进展性脑积水为表现的原发性柔脑膜淋巴瘤:通过内镜下室管膜活检和第三脑室造瘘术进行诊断及症状缓解
Cureus. 2025 Feb 6;17(2):e78611. doi: 10.7759/cureus.78611. eCollection 2025 Feb.
5
Isolated Third Cranial Nerve Palsy As the Initial Presentation of Primary Central Nervous System Lymphoma: A Rare Case.孤立性第三脑神经麻痹作为原发性中枢神经系统淋巴瘤的首发表现:1例罕见病例
Cureus. 2024 Dec 14;16(12):e75715. doi: 10.7759/cureus.75715. eCollection 2024 Dec.
6
MRI-Based Machine Learning for Prediction of Clinical Outcomes in Primary Central Nervous System Lymphoma.基于磁共振成像的机器学习用于预测原发性中枢神经系统淋巴瘤的临床结局
Life (Basel). 2024 Oct 11;14(10):1290. doi: 10.3390/life14101290.
7
Prognostic Impacts of Age, Diagnosis Time, and Relapses in Primary CNS Lymphoma.年龄、诊断时间及复发对原发性中枢神经系统淋巴瘤的预后影响
J Clin Med. 2024 Aug 13;13(16):4745. doi: 10.3390/jcm13164745.
8
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma.一大群原发性中枢神经系统淋巴瘤患者的演变性实变模式及预后
Blood Adv. 2024 Dec 24;8(24):6195-6206. doi: 10.1182/bloodadvances.2024013780.
9
Primary CNS Burkitt Lymphoma Presenting as Sudden Bilateral Blindness in a Patient With Underlying Kabuki Syndrome: A Case Report.原发性中枢神经系统伯基特淋巴瘤表现为一名患有歌舞伎综合征患者的突发性双侧失明:病例报告
Cureus. 2024 Jul 3;16(7):e63725. doi: 10.7759/cureus.63725. eCollection 2024 Jul.
10
Enhancing prognostication and treatment response evaluation in primary CNS lymphoma with 18F-FDG-PET/CT.利用18F-FDG-PET/CT增强原发性中枢神经系统淋巴瘤的预后评估和治疗反应评估。
Neuro Oncol. 2024 Dec 5;26(12):2377-2387. doi: 10.1093/neuonc/noae146.

本文引用的文献

1
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.原发性中枢神经系统淋巴瘤发病和生存的年龄、性别和种族差异。
Br J Cancer. 2011 Oct 25;105(9):1414-8. doi: 10.1038/bjc.2011.357. Epub 2011 Sep 13.
2
Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens.原发性中枢神经系统淋巴瘤:基于阵列的比较基因组杂交技术在福尔马林固定石蜡包埋肿瘤标本中的验证研究。
Clin Cancer Res. 2011 Jul 1;17(13):4245-53. doi: 10.1158/1078-0432.CCR-11-0395. Epub 2011 May 11.
3
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.卡波西肉瘤的流行病学、发病机制和治疗的最新进展。
Cancer Lett. 2011 Jun 28;305(2):150-62. doi: 10.1016/j.canlet.2011.02.006. Epub 2011 Mar 4.
4
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.免疫豁免部位原发性弥漫性大B细胞淋巴瘤的基因组改变与基因表达:凋亡和免疫调节通路的重要性
J Pathol. 2008 Oct;216(2):209-17. doi: 10.1002/path.2399.
5
AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003.艾滋病相关原发性中枢神经系统淋巴瘤:1989 - 2003年挪威全国性调查
BMC Cancer. 2008 Aug 6;8:225. doi: 10.1186/1471-2407-8-225.
6
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.1992 - 2001年美国按世界卫生组织亚型划分的淋巴瘤发病模式。
Blood. 2006 Jan 1;107(1):265-76. doi: 10.1182/blood-2005-06-2508. Epub 2005 Sep 8.
7
The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.原发性中枢神经系统非霍奇金淋巴瘤发病率持续上升:一项监测、流行病学及最终结果分析
Cancer. 2002 Oct 1;95(7):1504-10. doi: 10.1002/cncr.10851.
8
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.自高效抗逆转录病毒治疗时代以来艾滋病相关淋巴瘤的变化。
Blood. 2001 Oct 15;98(8):2339-44. doi: 10.1182/blood.v98.8.2339.
9
Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study.高龄人群中CD8和CD4淋巴细胞亚群的变化、T细胞增殖反应及非存活情况:瑞典纵向OCTO免疫研究
Mech Ageing Dev. 1998 May 15;102(2-3):187-98. doi: 10.1016/s0047-6374(97)00151-6.